Skip to content

Genotype and Phenotype Registry: Enrollment of Normal Control Subjects for Current and Future Research

TAP0307: Enrollment of Normal Control Subjects for Current and Future Research

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00926042
Enrollment
4511
Registered
2009-06-23
Start date
2004-02-29
Completion date
2012-08-31
Last updated
2016-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Healthy, volunteer, Healthy controls, Normal controls

Brief summary

Registry program for volunteers who are willing to serve as control subjects in future research studies.

Detailed description

The registry is a collection of volunteers willing to participate as control subjects in research studies. Control subjects are people who do not have a specific disease; therefore they can serve a critical role as a comparison with people who have the disease or other characteristic being studied. Once registered, participants will be notified about studies they may be able to participate in as a control. Participation requires: 1. signing a consent form 2. answering a short health survey 3. providing a DNA sample via a mouthwash kit The registry allows scientists to select study participants based on whether or not they have a specific genetic change that may be relevant to a disease under investigation. Having the ability to access controls when needed is an extremely valuable resource that will speed up scientific discoveries.

Interventions

None listed

Sponsors

Northwell Health
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Generally healthy * over age 18

Exclusion criteria

* under age 18

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026